Osmium(VI) complexes as a new class of potential anti-cancer agents (Q34157363)

31 July 2017

title

Osmium(VI) complexes as a new class of potential anti-cancer agents (English)

1 reference

31 July 2017

1 reference

Tai-Chu Lau

8

0 references

Chi-Ming Che

7

object named as

Chi-Ming Che

1 reference

31 July 2017

Wen-Xiu Ni

1

1 reference

31 July 2017

Wai-Lun Man

2

1 reference

31 July 2017

Myra Ting-Wai Cheung

3

1 reference

31 July 2017

Raymond Wai-Yin Sun

4

1 reference

31 July 2017

Yuan-Lan Shu

5

1 reference

31 July 2017

Yun-Wah Lam

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

4 January 2011

1 reference

31 July 2017

published in

Chemical Communications

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

2140-2142

1 reference

The resurgence of platinum-based cancer chemotherapy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Metal complexes in medicine with a focus on enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Biological inorganic chemistry at the beginning of the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Gold-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Bleomycin: revival of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Ruthenium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Ruthenium antimetastatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Recent developments in the field of tumor-inhibiting metal complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

[Os(IV)Cl(5)(Hazole)](-) complexes: synthesis, structure, spectroscopic properties, and antiproliferative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

G-quartets 40 years later: from 5'-GMP to molecular biology and supramolecular chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

Facile Nucleophilic Addition to Salophen Coordinated to Nitridoosmium(VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0CC04515B

21 January 2018

Identifiers

DOI

10.1039/C0CC04515B

1 reference

release_fjg5s2iecjgwjcou5ydx34pbjy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fjg5s2iecjgwjcou5ydx34pbjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference